Net Clinical Benefit for Anticoagulation, Aspirin, or No Therapy in Low-Risk AF

Study Questions:

What is the net clinical benefit (NCB) of aspirin or warfarin as compared to no antithrombotic therapy among atrial fibrillation (AF) patients at low risk for stroke?